Circulation published a clinical update in Cardiology on 30 Mar 2026. The item focuses on Pulmonary Arterial Hypertension Risk With BCR-ABL Tyrosine Kinase Inhibitors: Refining Risk With Nationwide Data. Review the original article for the full source wording and details.
Circulation published a clinical update in Cardiology on 30 Mar 2026.
The item focuses on Pulmonary Arterial Hypertension Risk With BCR-ABL Tyrosine Kinase Inhibitors: Refining Risk With Nationwide Data.
Review the original article for the full source wording and details.